Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
As of today, Gilead Sciences(GILD) shares are valued at $131.10. The company's market cap stands at 163.02B, with a P/E ratio of 17.87 and a dividend yield of 2.4%.
As of 2026-05-10, Gilead Sciences(GILD) stock has fluctuated between $129.00 and $133.34. The current price stands at $131.10, placing the stock +1.6% above today's low and -1.7% off the high.
Gilead Sciences(GILD) shares are trading with a volume of 10.15M, against a daily average of 6.89M.
During the past year, Gilead Sciences(GILD) stock moved between $96.19 at its lowest and $157.29 at its peak.
During the past year, Gilead Sciences(GILD) stock moved between $96.19 at its lowest and $157.29 at its peak.
GILD News
Gilead Sciences ((GILD)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and pow...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Gilead stock toppled late Thursday after the drugmaker issued a mixed guidance despite beating first-quarter sales expectations on the back of its HIV drugs Bik...
Analyst ratings
75%
of 32 ratingsMore GILD News
Gilead Sciences (GILD) recently drew attention after the FDA accepted its New Drug Application for a once daily bictegravir and lenacapavir HIV tablet. The appl...
Gilead Sciences, Inc. (NASDAQ:GILD) will release earnings for its first quarter after the closing bell on Thursday, May 7. Analysts expect the Foster City, Cal...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
On 20 April 2026, Arcus Biosciences and Gilead Sciences discontinued the Phase 3 STAR-121 and Phase 2 EDGE-Lung studies in metastatic non-small cell lung cancer...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.